pooled CV from MR vs. IR [Power / Sample Size]

posted by ElMaestro  – Denmark, 2018-01-18 18:03 (2656 d 11:27 ago) – Posting: # 18217
Views: 4,607

Hi Hötzi,

❝ I suggest to perform a pilot study, a Two-Stage Design, or – if you want to go directly to the pivotal study – allow for a safety margin.


The generic way: Contact 37 different CRO's for a quotation for Biperiden IR filmcoated tablets, tell them you expect a T/R ratio of 106% or whatever on basis of dissolution studies and you hope for 80% power.
Some of them will respond back with a quotation involving a specific sample size, so you ask naïvely where that comes from. Then they will say that in the previous study they conducted on Biperiden IR the CV was so-and-so with this or that design "but please keep this information confidential". And voila, you have totally wasted a lot of time for employees in a boatload of companies but you got the type of information you were looking for.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
101 visitors (0 registered, 101 guests [including 3 identified bots]).
Forum time: 06:31 CEST (Europe/Vienna)

There are two possible outcomes: if the result confirms the
hypothesis, then you’ve made a measurement. If the result is
contrary to the hypothesis, then you’ve made a discovery.    Enrico Fermi

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5